Electroencephalography

Global Wireless Brain Sensors Market Expected to Garner $1,566.7 Million by 2031, Growing at 9.0% CAGR from 2022 to 2031 [280-Pages] | Report by Research Dive

Retrieved on: 
星期三, 三月 1, 2023
Brain, Stroke, Traumatic brain injury, Urbanization, Migraine, Research, Hospital, MEG, Brain damage, Growth, EEG, COVID-19, Incidence, Disease, Prevalence, Medical imaging, Mobile phone, Alzheimer's disease, Electroencephalography, Epilepsy, Magnetoencephalography

NEW YORK, March 1, 2023 /PRNewswire/ -- Research Dive has added a new report to its offering titled, "Wireless Brain Sensors Market by Product Type (Electroencephalography (EEG) devices, Sleep Monitoring Devices, Magnetoencephalography (MEG) Devices, and Others), Application (Alzheimer's Disease, Traumatic Brain Injury, Epilepsy, Sleep Disorders, and Others), and End User (Hospitals, Research and Academic Institute/Laboratories, Homecare Settings, and Others): Global Opportunity Analysis and Industry Forecast, 2022-2031".

Key Points: 
  • The wireless brain sensors market is expected to grow in the 2021-2031 timeframe, due to the growing cases of traumatic brain injuries.
  • As per the report, the global wireless brain sensors market is predicted to grow at a stable CAGR of 9.0% in the 2022-2031 timeframe, thereby garnering $1,566.7 million by 2031.
  • Restraints: High cost of using wireless brain sensors, however, may dampen the growth rate of the wireless brain sensors market.
  • By regional analysis, the wireless brain sensors market in North America region is expected to flourish immensely in the forecast period.

$1.63 Bn Neuromarketing Solution Markets by Technology, Electroencephalography, Eye tracking, Positron Emission Tomography and Magnetoencephalography - Global Forecasts to 2030 - ResearchAndMarkets.com

Retrieved on: 
星期四, 一月 26, 2023
Marketing, Communications, Pfizer, Investment, Neuroscience, Region, Positron emission tomography, Bain Capital, Neuropsychiatry, Behavior, Growth, US, Perception, Advertising, Neuromarketing, Renewable energy, Magnetoencephalography, Electroencephalography

The "Neuromarketing Solution Market, By Technology, Electroencephalography, Eye tracking, Positron Emission Tomography and Magnetoencephalography, By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Neuromarketing Solution Market, By Technology, Electroencephalography, Eye tracking, Positron Emission Tomography and Magnetoencephalography, By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • Moreover the primary objective behind neuromarketing is to understand the rationale behind how consumers make a decision for purchasing.
  • Rising investments in the field of neuroscience is the major factor driving the growth of global neuromarketing solution market.
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global Neuromarketing Solution market.

MicroCloud Hologram (NASDAQ: HOLO) Announces the Launch of A Holographic Brain-Computer Interface(BCI) Data Acquisition System

Retrieved on: 
星期四, 一月 26, 2023
Human, BCI, Algorithm, DSP, Brain, Robotics, Brain–computer interface, EEG, Electroencephalography, Acquisition, AD, Multimedia, Research, Medical imaging, Computer data storage

BEIJING, Jan. 26, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced the launch of its holographic BCI (Brain-Computer Interface) data acquisition system.

Key Points: 
  • BEIJING, Jan. 26, 2023 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO) ("HOLO" or the "Company"), a Hologram Digital Twins Technology provider, today announced the launch of its holographic BCI (Brain-Computer Interface) data acquisition system.
  • HOLO's holographic BCI data acquisition system combines BCI with holographic technology, enabling the two technologies to complement each other.
  • HOLO's holographic brain computer interface data acquisition system includes EEG amplification holographic data generation part, digital control part and intelligent algorithm part.
  • Eeg amplifier circuit is mainly used to complete the holographic data amplification of EEG, so as to facilitate the subsequent holographic data processing of EEG acquisition system.

Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS

Retrieved on: 
星期三, 一月 18, 2023
Neuro, Electromyography, EEG, Polysomnography, EMG, Sensory, Electroencephalography, ICU, Diagnosis, Growth, Patient, PSG, Acquisition, Risk management, Micromation

MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company" or "Natus"), a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, today announced the closing of its acquisition of Micromed Holding SAS ("Micromed"), a global provider of neurophysiology solutions.  Micromed products will be added to the Natus Neuro portfolio and developed alongside Natus technologies.

Key Points: 
  • MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company" or "Natus"), a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, today announced the closing of its acquisition of Micromed Holding SAS ("Micromed"), a global provider of neurophysiology solutions.
  • Micromed products will be added to the Natus Neuro portfolio and developed alongside Natus technologies.
  • "We are thrilled to complete this deal and move forward combining the Natus and Micromed teams and product portfolios," said Austin Noll, Natus President and leader of Natus Neuro.
  • "The acquisition of Micromed is the first transaction in our acquisition roadmap to build leading companies in both Neuro and Sensory under the Natus umbrella," said Thomas J. Sullivan, Natus Chief Executive Officer.

Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS

Retrieved on: 
星期三, 一月 18, 2023
Neuro, Electromyography, EEG, Polysomnography, EMG, Sensory, Electroencephalography, ICU, Diagnosis, Growth, Patient, PSG, Acquisition, Risk management, Micromation

MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company" or "Natus"), a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, today announced the closing of its acquisition of Micromed Holding SAS ("Micromed"), a global provider of neurophysiology solutions.  Micromed products will be added to the Natus Neuro portfolio and developed alongside Natus technologies.

Key Points: 
  • MIDDLETON, Wis., Jan. 18, 2023 /PRNewswire/ -- Natus Medical Incorporated (the "Company" or "Natus"), a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, today announced the closing of its acquisition of Micromed Holding SAS ("Micromed"), a global provider of neurophysiology solutions.
  • Micromed products will be added to the Natus Neuro portfolio and developed alongside Natus technologies.
  • "We are thrilled to complete this deal and move forward combining the Natus and Micromed teams and product portfolios," said Austin Noll, Natus President and leader of Natus Neuro.
  • "The acquisition of Micromed is the first transaction in our acquisition roadmap to build leading companies in both Neuro and Sensory under the Natus umbrella," said Thomas J. Sullivan, Natus Chief Executive Officer.

Sensus Healthcare Announces Senior Management Appointments and Promotions

Retrieved on: 
星期一, 一月 9, 2023
Sentinel, Eclipse, Air force, Social media, Research, Information, Santa Clara University, Dermatology, Respect, University, San Jose State University, SCU Leavey School of Business, Business, Concordia University Texas, Quality assurance, Stetson University, Electroencephalography, Physics, Digital marketing, Second lieutenant, National university, Brain, Food and Drug Administration, Concordia University, Kyiv National University of Technologies and Design, Biology, Penn State Air Force ROTC, Marketing, Food, Growth, Moses Austin, Engineering, Patient, University of Buenos Aires, Intelligence, Software, Workforce, BOCA, Industrial, MBA, Regulation, Small business, GPS, Medical imaging, Management, Medical device, Cynosure, SensUs, Operation, EU

BOCA RATON, Fla, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce the following promotions and appointments to its management team:

Key Points: 
  • BOCA RATON, Fla, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, is pleased to announce the following promotions and appointments to its management team:
    Ms. Martinez joined Sensus nine years ago and subsequently held positions of increasing responsibility.
  • Mr. Sosa joined Sensus last year as Vice President of Technology Development with extensive experience in banking, cyber security and artificial intelligence.
  • I am delighted to announce these promotions and appointments and look forward to the contributions of these talented individuals as Sensus executes on an aggressive business strategy,” said Joe Sardano, chairman and chief executive officer of Sensus Healthcare.
  • “Our goal is for Sensus to be a destination for great employees from all walks of life and backgrounds.

Brain Mapping Instruments Market to Witness CAGR of 13% (2022-2028) on account of Increasing Prevalence of Neurodegenerative Disorders | UnivDatos Market Insights

Retrieved on: 
星期二, 十二月 6, 2022
Neuroimaging, Hospital, Neurological disorder, Medtronic, Brain mapping, Transport, PET, Diagnosis, Stroke, Prevalence, Sleep, CAT, Epilepsy, Magnetoencephalography, Magnetic resonance, Infrared spectroscopy, EGG, World Health Organization, Electroencephalography, COVID-19, Behavior, Midsayap Diagnostic Center and Hospital, Growth, EEG, WHO, Brain, Magnetic resonance imaging, Social isolation, Multiple sclerosis, Seizure, CDC, USD, Medical imaging, NOIDA

This innovative report makes use of several analyses to get a closer outlook on the brain mapping instruments market.

Key Points: 
  • This innovative report makes use of several analyses to get a closer outlook on the brain mapping instruments market.
  • Furthermore, this statistical market research repository examines and estimates the brain mapping instruments market at the global and regional levels.
  • Furthermore, the rising prevalence of brain disorders coupled with the increasing efforts to understand the brain complexities for future disease treatment catalyzing the market growth of brain mapping instruments.
  • Brain Mapping Instruments Market Geographical Segmentation Includes:
    North America constitutes a significant brain mapping instruments market due to the increasing R&D activities and frequent product launches in the region.

Brain Mapping Instruments Market to Witness CAGR of 13% (2022-2028) on account of Increasing Prevalence of Neurodegenerative Disorders | UnivDatos Market Insights

Retrieved on: 
星期二, 十二月 6, 2022
Neuroimaging, Hospital, Neurological disorder, Medtronic, Brain mapping, Transport, PET, Diagnosis, Stroke, Prevalence, Sleep, CAT, Epilepsy, Magnetoencephalography, Magnetic resonance, Infrared spectroscopy, EGG, World Health Organization, Electroencephalography, COVID-19, Behavior, Midsayap Diagnostic Center and Hospital, Growth, EEG, WHO, Brain, Magnetic resonance imaging, Social isolation, Multiple sclerosis, Seizure, CDC, USD, Medical imaging, NOIDA

This innovative report makes use of several analyses to get a closer outlook on the brain mapping instruments market.

Key Points: 
  • This innovative report makes use of several analyses to get a closer outlook on the brain mapping instruments market.
  • Furthermore, this statistical market research repository examines and estimates the brain mapping instruments market at the global and regional levels.
  • Furthermore, the rising prevalence of brain disorders coupled with the increasing efforts to understand the brain complexities for future disease treatment catalyzing the market growth of brain mapping instruments.
  • Brain Mapping Instruments Market Geographical Segmentation Includes:
    North America constitutes a significant brain mapping instruments market due to the increasing R&D activities and frequent product launches in the region.

Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022

Retrieved on: 
星期一, 十二月 5, 2022
Seoul National University Bundang Hospital, Drowning, Seizure, Epilepsy, Accident, Ageing, AES, SK, American Epilepsy Society, Central nervous system, Neurological disorder, Falling, Patient, SUDEP, Research, Central nervous system disease, Death, Brain, World Health Organization, Electroencephalography, Epilepsy Foundation, Multimedia, EEG, Safety, Work, Depression, CNS, Risk, Pharmaceutical industry, Medical device

PANGYO, South Korea, Dec. 4, 2022 /PRNewswire/ -- Seoul National University Bundang Hospital (SNUBH) presented its preliminary study result of seizure monitoring for patients with epilepsy using SK Biopharmaceuticals' multimodal wearable device at the American Epilepsy Society (AES) Annual Meeting 2022 in Nashville, Tennessee, December 2-6. This is the first study of the wearable device developed by SK Biopharmaceuticals, an innovative global pharmaceutical company.

Key Points: 
  • PANGYO, South Korea, Dec. 4, 2022 /PRNewswire/ -- Seoul National University Bundang Hospital (SNUBH) presented its preliminary study result of seizure monitoring for patients with epilepsy using SK Biopharmaceuticals' multimodal wearable device at the American Epilepsy Society (AES) Annual Meeting 2022 in Nashville, Tennessee, December 2-6.
  • This is the first study of the wearable device developed by SK Biopharmaceuticals, an innovative global pharmaceutical company.
  • SK Biopharmaceuticals and SNUBH plan to further pursue clinical research with Zero WiredTM, aiming to develop it into an AI-based seizure detection and forecast device.
  • Zero Wired, a CES 2023 Innovation Awards Honoree, is an upgraded version of the multimodal wearable device used in the SNUBH pilot study.

Zeto Implements encevis' Seizure Detection and Trending Algorithms

Retrieved on: 
星期四, 十二月 1, 2022
Software, Deep learning, Electroencephalography, AI, AIT, Hospital, Physician, Patient, Neurological disorder, Seizure, EEG, National Association Medical Staff Services, Research, FDA, Algorithm, Medical imaging, Zeto

SANTA CLARA, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Zeto, Inc. , an innovative EEG brain monitoring company, announced today the integration of FDA cleared seizure detection and trending algorithms developed by encevis , now available as part of the Zeto EEG platform.

Key Points: 
  • SANTA CLARA, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Zeto, Inc. , an innovative EEG brain monitoring company, announced today the integration of FDA cleared seizure detection and trending algorithms developed by encevis , now available as part of the Zeto EEG platform.
  • The trending module graphically reports several hours of EEG into a simple display to allow rapid assessment of brain states.
  • The seizure detection component offers high sensitivity with low false alarm rates, matching and in parts surpassing industry benchmarks.
  • "We are excited to integrate encevis' seizure detection and trending tools into our platform.